MOTIFENE 75MG CAPSULES

Active substance: DICLOFENAC SODIUM

View full screen / Print PDF » Download PDF ⇩

Transcript
Package Leaflet: Information for the User

Motifene® 75 mg Capsules
diclofenac sodium
Read all of this leaflet carefully before you start taking this medicine.
– Keep this leaflet. You may need to read it again.
– If you have any further questions, please ask your doctor or pharmacist.
– This medicine has been prescribed for you. Do not give it to anyone else. It may harm them,
even if their symptoms are the same as yours.
– If any of the side effects become serious, or if you notice any side effects not listed in this leaflet,
please tell your doctor or pharmacist.
In this leaflet:
1. What is Motifene and what is it used for?
2. Before you take Motifene
3. How to take Motifene
4. Possible side effects
5. How to store Motifene
6. Further information
1. WHAT IS MOTIFENE AND WHAT IS IT USED FOR?
Diclofenac sodium, the active ingredient in Motifene 75 mg Capsules, is one of a group of
medicines called non-steroidal anti-inflammatory drugs (NSAIDs) and is used to reduce pain and
inflammation. Some of the pellets inside the Motifene capsule shell release diclofenac quickly to
give a rapid effect (gastro-resistant pellets). The remainder of the pellets dissolve more slowly to
produce a longer lasting effect (prolonged release pellets).
Motifene can be used for the treatment of pain and inflammation due to:
– Acute attacks of gout
– Acute musculo-skeletal disorders (for example frozen shoulder, inflamed tendons)
– Dental or other minor surgery
– Joint disorders (such as ankylosing spondylitis, osteoarthritis, rheumatoid arthritis)
– Traumatic conditions (including sprains, strains, dislocations, fractures)
– Low back pain.
2. BEFORE YOU TAKE MOTIFENE
Do not take the capsules if
– you have had an allergic reaction to any of the ingredients in Motifene 75 mg Capsules (see
‘6. Further information’ below)
– you have had an allergic reaction to ibuprofen, aspirin or other NSAIDs
– you have severe liver, kidney or heart failure
– you are in the last three months of pregnancy
– you have a peptic ulcer (ulcer in your stomach or duodenum) or bleeding in your stomach
(for example, passed black tarry or bloody stools or vomited blood or dark particles that look
like coffee grounds), or have had two or more episodes of peptic ulcers, stomach bleeding or
perforation.
If you think any of these apply to you, or you are unsure, do not take the capsules. Talk to your
doctor first and follow the advice given.
Take special care with Motifene
Talk to your doctor before taking Motifene if you are also taking other NSAIDs, as Motifene should
not be used at the same time as other NSAIDs.
If you have any of the following health problems, you may need to take special care while taking the
medicine as your condition could get worse:
– Asthma, hayfever or other allergies, polyps in your nose, difficulty breathing (COPD), long term
respiratory infections
– Crohn's disease or ulcerative colitis
– SLE (Systemic Lupus Erythematosus), an inflammation of the connective tissue
– Heart, kidney or liver problems (your doctor may want to carry out some tests while you are
taking the capsules)
– High blood pressure.
– Acute porphyria
– Blood clotting problems
Tell your doctor if you are about to have major surgery.
Because Motifene is a NSAID, it can make the symptoms of an infection (such as fever, pain) less
noticeable.
Medicines such as Motifene may be associated with a small increased risk of heart attack
(“myocardial infarction”) or stroke. Any risk is more likely with high doses and prolonged treatment.
Do not exceed the recommended dose or duration of treatment.
If you have heart problems, previously had a stroke or think that you might be at risk of these
conditions (for example if you have high blood pressure, diabetes or high cholesterol or are a
smoker) you should discuss your treatment with your doctor or pharmacist.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines,
including medicines obtained without a prescription. You may still be able to take Motifene if you
are taking these medicines, but you must discuss this matter with your doctor and be advised
before taking any of the medicines listed below:
– Other painkillers or anti-inflammatory drugs (NSAIDs), including aspirin, or any other medicines
used to prevent platelet clumping
– Medicines to lower blood pressure (anti-hypertensives)
– Anti-coagulants, such as warfarin (to "thin" the blood)
– Anti-diabetic tablets
– Certain antibiotics, such as ciprofloxacin
– Ciclosporin or tacrolimus (immunosuppressive medicines, used to dampen down the body's
immune reactions)
– Corticosteroids
– Mifepristone (for early termination of pregnancy)
– Heart drugs, such as digoxin
– Diuretics ("water tablets"), including the potassium-sparing type
– Lithium (a medicine used to treat mood swings and some types of depression)

Selective serotonin reuptake inhibitors (SSRIs) (medicines used to treat some types of depression)
– Methotrexate (a medicine used to treat arthritis and some types of cancer)
– Zidovudine (a medicine used to treat HIV and AIDs).
– Phenytoin (used to treat epilepsy)
– Colestipol or cholestyramine (medicines used to lower cholesterol levels)
– Voriconazole (used to treat fungal infections)
– Sulfinpyrazone (used to treat gout)
Children
These capsules are not suitable for children.
Elderly patients
If you are elderly, your doctor may want to monitor you carefully while you are taking Motifene.
Pregnancy and breast feeding
Tell your doctor before taking Motifene if you are pregnant or breast feeding. As with other
non-steroidal anti-inflammatory drugs, Motifene may make it more difficult to become pregnant.
You should inform your doctor if you are planning to become pregnant or if you have problems
becoming pregnant.
Motifene must not be taken during the last three months of pregnancy (see “Do not take the
capsules” above). It is not usually recommended at other stages of pregnancy, but you may be able
to take it if your doctor advises that it is necessary for you.
Motifene should be avoided if you are breast feeding, as small amounts of the medicine may pass
into breast milk.
Driving and using machines
These capsules can cause some people to feel dizzy or giddy, drowsy or sleepy, tired or have problems with their vision. If you are affected, do NOT drive or operate machinery.
GB 110832

3. HOW TO TAKE MOTIFENE
Motifene 75 mg Capsules must be swallowed whole with a drink of water (about half a glass). Do
not chew or break open the capsules. The capsules are best taken with or after food. It may help
you to remember to take your capsules if you take them at the same time every day, perhaps with
breakfast or an evening meal.
Dosage
The usual dose is ONE capsule of Motifene, ONCE or TWICE a day as prescribed.
It is important that the second dose is taken 8–12 hours after the first dose and that no more than
two Motifene 75 mg Capsules are taken in any 24 hour period.
Tell your doctor if you have any concerns about your treatment.
If you take more Motifene than you should
If you take more capsules than you should or if a child accidentally swallows some, go to your
doctor or nearest emergency department immediately and take your medicine pack with you.
If you forget to take Motifene
If it is a little more than 12 hours since your previous dose, take the missed dose and then adjust
the timing of your next dose to 8–12 hours later. Do not take a double dose to make up for the one
you forgot and do not take more than two capsules in 24 hours.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Motifene can cause side effects, although not everybody gets them. Taking the
lowest effective dose for the shortest possible time will minimise side effects.
Some side effects can be serious. STOP taking Motifene 75 mg Capsules and tell your doctor
immediately if you notice any of the following symptoms:
– Stomach ulcer or duodenal ulcer
– Passing blood in your faeces (stools/motions)
– Bleeding from the stomach or intestines (e.g. passing black ‘tarry’ stools)
– Vomiting blood or dark particles that look like coffee grounds
– Stomach pains or other abnormal stomach symptoms
– Indigestion or heartburn
– Worsening of Crohn’s disease or of ulcerative colitis
– Allergic reactions, which can include sudden wheeziness, difficulty in breathing, swelling of the
face, lips, hands or fingers, skin rash, itching, bruising, painful red areas, peeling or blistering.
You should tell your doctor or pharmacist if you notice any of the side effects listed below or any
others not mentioned. You will be advised if you need to stop the medicine. (If any of them is severe
stop the medicine and then tell your doctor.)
Other common side effects include:
Sickness, feeling sick, flatulence, diarrhoea, constipation (including blockages), problems swallowing,
loss of appetite, swelling of the tongue.
Other less common side effects include:
Kidney problems, urinary problems (e.g. any change in the usual amount or colour of the urine),
liver problems, jaundice (yellowing of the skin or whites of the eyes), blurred vision, double vision,
headache, pins and needles, stiff neck, depression, confusion, hallucinations, tinnitus (ringing in the
ears), dizziness or giddiness, feeling unwell, tiredness, sleepiness, sensitivity to light, rashes and
spots, flaky skin, changes in blood test results.
Reports of isolated cases include:
Memory problems, disorientation, impaired hearing, insomnia, irritability, fits, anxiety, nightmares,
tremor, mood changes, changes in taste, hair loss, eczema and unusual bruising.
Very rare reports include:
Skin rashes, blisters on the skin and sore mouth/eyes, inflammation of the pancreas.
Other effects:
Medicines such as Motifene may be associated with a small increased risk of heart attack
(“myocardial infarction”) or stroke.
Other side effects reported in association with non-steroidal anti-inflammatory drugs include
swelling caused by a build-up of fluid (known as ’oedema‘), high blood pressure palpitations, chest
pain and heart failure.
Your doctor may require you to have occasional check-ups while you are taking Motifene 75 mg
Capsules.
5. HOW TO STORE MOTIFENE
Keep this medicine out of the reach and sight of children.
Motifene 75 mg Capsules should not be stored above 25ºC.
Do not use the medicine after the expiry date printed on the box and on the blister strip. The expiry
date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how
to dispose of medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION
What Motifene 75 mg Capsules contain
The active substance is diclofenac sodium.
Each hard gelatin capsule contains 75 mg diclofenac sodium.
Other ingredients:
Gastro-resistant pellets:
Microcrystalline cellulose, Povidone K25, colloidal anhydrous silica, methacrylic acid ethyl acrylate
copolymer, propylene glycol, talc.
Prolonged release pellets:
Microcrystalline cellulose, Povidone K25, colloidal anhydrous silica, ammonio methacrylate copolymer
A and B, triethyl citrate, talc.
Capsule shell:
Indigocarmine (E132), titanium dioxide (E171), gelatin.
Capsule body:
Gelatin, ink (containing shellac, propylene glycol, titanium dioxide (E171)).
What Motifene looks like and contents of the pack
Motifene 75 mg Capsules are blue and clear and are marked ‘D 75 M’.
The capsules are available in packs of 2, 4, 28 and 56.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Manufacturer
DAIICHI SANKYO UK Ltd
Temmler Werke GmbH
Chiltern Place
Weihenstephaner Straße 28
Chalfont Park
D-81673
Gerrards Cross
Munich
Buckinghamshire
Germany
SL9 0BG
UK
This leaflet was last approved in October 2012

Problems reading this leaflet?
To listen to or request a copy of this leaflet in Braille, large print
or audio, please call, free of charge 0800 198 5000 (UK only)
Please be ready to give the following information:
Product name: Motifene 75 mg Capsules
Reference Number: PL 08265/0003
This is a service provided by the Royal National Institute of
Blind People.
308962-2130

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)